Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
So low cost! It's worth geting penis vibrator in our Sex Toys Store.
Popular Articles

Bathtub Danger: Thousands Of Kids Injured Each Year In Slips And Falls
More than 43,000 children are injured in bathtubs and showers every year, mostly from slips and falls, according to the study, "Injuries Associated With Bathtubs and Showers Among Children in the United States." While bathtub injuries associated with tap water burns and submersions have generated much research, this is the first study using nationally representative data to look at injuries from slips and falls, which are responsible for the majority of bathtub injuries. Using data from the National Electronic Injury Surveillance System of the U.S. Consumer Product Safety Commission from 1990 to 2007, researchers evaluated an estimated 791,200 bathtub- and shower-related injuries during the 18-year study period among children 18 years old and younger who were treated in U.S. emergency departments.
pharmacy online Dentisti fiume
BioVex To Report Phase I/II Clinical Trial Results For The Front Line Treatment Of Head And Neck Cancer
BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.
News of the day
New Summer Safety Warning To Children In Scotland About Construction Sites Dangers, UK
The Health and Safety Executive (HSE) has issued a new warning urging parents in Scotland to keep their children away from construction sites so they stay safe.
Health Insurance

Inconclusive Research Links Glargine Insulin (Lantus) With Cancer

Diabetes UK has today cautioned that research claiming there is a link between certain insulins and some cancers is "inconclusive". Results of four studies looking at the risk of cancer largely in people with Type 2 diabetes treated with insulin, particularly glargine insulin (Lantus), were published in Diabetologia - the Journal of the European Association for the Study of Diabetes - last week. The studies were based in Germany, Sweden, Scotland and the UK. The data of around 300,000 people treated with insulin was reviewed in the studies, of which 34,392 were taking glargine insulin (Lantus) alone. The German study suggested there may be a small increased risk of cancer in those taking glargine as their only insulin; with the strongest link seeming to be with breast cancer in older people. This small increase in risk appeared in two of the other three studies and seemed to be more so in people on high doses. Sir Professor George Alberti, Chairman of Diabetes UK, said: "It should be stated firmly that the evidence in these studies is not conclusive and that there are limitations with the research. "People with diabetes who are using glargine insulin should continue to take their medication as prescribed. You will become very ill if you stop taking your insulin. If you are concerned about these findings then you should speak to your healthcare team about your anxieties before discontinuing any treatment." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009